Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/16/2025

Insulin Degludec Dosing and Treatment Plan for Type 1 and Type 2 Diabetes

Combination Therapy Options

  • When basal insulin has been titrated to an acceptable fasting blood glucose but HbA1c remains above target, consider advancing to combination injectable therapy, as recommended by the American Diabetes Association, 1
  • In type 2 diabetes, if basal insulin alone is insufficient, combination with a GLP-1 receptor agonist can be considered before advancing to multiple daily injections, according to the American Diabetes Association, 1
  • Fixed combination products containing insulin degludec plus liraglutide (IDegLira) are available and may simplify treatment, as noted by the American Diabetes Association, 1
  • When initiating combination injectable therapy, metformin therapy should be maintained, while sulfonylureas and DPP-4 inhibitors are typically discontinued, as recommended by the American Diabetes Association, 1
  • For patients requiring complex insulin regimens, adjunctive use of SGLT2 inhibitors may help improve control and reduce insulin requirements, according to the American Diabetes Association, 1 and other sources, 4

Special Considerations

  • For patients who experience frequent severe hypoglycemia with human insulin, long-acting insulin analogues like insulin degludec should be considered, as suggested by the American College of Physicians, 2 and 3